
Dr. Charles S Hesdorffer MD
Hematologist-Oncologist | Hematology & Oncology
3001 S Hanover St Nia At Harbor Hospit Brooklyn MD, 21225About
Dr. Charles Hesdorffer is a hematologist oncologist practicing in Brooklyn, MD. Dr. Hesdorffer specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
University of The Witwatersrand, Faculty of Health Sciences,Parktown, South Africa 1978
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Wild-type p53 epitope naturally processed and presented by an HLA-B haplotype on human breast carcinoma cells.
- A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors.
- CD34+ cell dose requirements for rapid engraftment in a sequential high-dose chemotherapy regimen of paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin (CTCb) with PBPC support in metastatic breast cancer.
- The pharmacokinetics and pharmacodynamics of high-dose paclitaxel monotherapy (825 mg/m2 continuous infusion over 24 h) with hematopoietic support in women with metastatic breast cancer.
- Reduction of paclitaxel-induced peripheral neuropathy with glutamine.
- Transcript profiling of human dendritic cells maturation-induced under defined culture conditions: comparison of the effects of tumour necrosis factor alpha, soluble CD40 ligand trimer and interferon gamma.
- Tandem transplantation in lymphoma.
- Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer.
- Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting.
- Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rate.
- A monoclonal melanoma-specific T-cell population phenotypically indistinguishable from CD3+ LGL-leukemia.
- Gene expression profiling and functional activity of human dendritic cells induced with IFN-alpha-2b: implications for cancer immunotherapy.
- SSX antigens as tumor vaccine targets in human sarcoma.
- Shifting gene expression profiles during ex vivo culture of renal tumor cells: implications for cancer immunotherapy.
- An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR.
Dr. Charles S Hesdorffer MD's Practice location
Dr. Charles Hesdorffer, MD
3001 S Hanover St Nia At Harbor Hospit -Brooklyn, MD 21225Get Direction
Dr. Charles S Hesdorffer MD's reviews
Write ReviewRecommended Articles
- AstraZeneca Gains United States Approval for Lymphoma Drug
Some forms of lymphoma are rarer than others. Most people can recognize Hodgkin lymphoma, but mantle cell lymphoma will strike them as a surprise.Because it is so rare, there are not as many drugs specific to this form of cancer. One has recently been approved in the United States, by the Food and...
- Inspirational Blood Cancer Survivors
Different forms of blood cancer are responsible for claiming the third most lives out of all the types of cancer. Additionally, there are currently no known preventative treatments for blood cancers, and the disease also impacts children and young people more than any other form of cancer.When it...
- How Dogs Are Helping with Lymphoma Research
According to the Cornell Chronicle (CC), Cornell and Tufts University have received a huge grant for the study of human lymphoma, using a humane approach to test on dogs.The dogs in the study will already have lymphoma and it’s hoped they’ll be cured in the process of this research study.There...
- John Quinones Teams Up With Survivors For Leukemia and Lymphoma Society
Many cancer patients suffer in silence, with the public being largely unaware of the different types of cancer and how they affect patients. Most people obviously know that cancer is well, a bad thing, but there is a lot of nuance and important information that is lost on the common citizen. Most...
- Living as a Hodgkin Lymphoma Survivor: Creating a New Normal
No one can ever truly be prepared for what it is like to live with cancer. Even the strongest survivors face setbacks, and some of the fiercest warriors share their stories of how they find their "new normals."Kimberly's storyWhen she was only 25, just five days before her wedding, Kimberly felt a...
- The Link Between Lymphoma Radiotherapy and Mesothelioma
One of the more common forms of treatment for lymphoma is radiotherapy. This involves using radiation to kill the cancer cells in the lymph nodes. New studies have produced concerning findings regarding radiation therapy, and point towards another induced risk of using the practice.The StudyThe...
Nearby Providers
- Dr. Yin Wu MD2401 W BELVEDERE AVE BALTIMORE MD 21215
- Ugochukwu A. Odo5406 FAIRLAWN AVE BALTIMORE MD 21215
- Dr. Jean Yared M.D.22 S Greene St Baltimore MD 21201
- Dr. Young Joo Lee M.D.3001 S Hanover St Brooklyn MD 21225
- Dr. Cristina I Truica M.D.2401 W Belvedere Avenue Baltimore MD 21215
- Dr. Vered Stearns M.D.1800 Orleans St Baltimore MD 21287